The University of Nevada, Reno School of Medicine (UNR Med) has reached a historic milestone in national medical research standings, securing its highest-ever position since tracking began in 2001.
In the 2025 rankings released by the Blue Ridge Institute for Medical Research (블루리지 의학연구소), UNR Med placed 93rd among 145 accredited medical schools nationwide — a benchmark that reflects the institution's accelerating investment in biomedical discovery.
The Blue Ridge rankings, widely regarded as an objective measure of institutional research strength, are calculated on the basis of competitive grant awards from the National Institutes of Health (NIH·국립보건원), the federal government's primary engine for biomedical funding. Because NIH grants require rigorous peer review, placement in these rankings signals demonstrated scientific capacity rather than institutional size alone.
At the departmental level, UNR Med posted particularly strong results.
The Department of Physiology and Cell Biology (생리세포생물학과) ranked 22nd out of 74 comparable programs nationally, securing $10,031,440 in NIH awards, while the Department of Pharmacology (약리학과) ranked 25th out of 79, with $10,236,683 in funding.
Combined, the two departments attracted more than $20.2 million — a figure that places UNR Med well within the upper tier of research-intensive programs in the Mountain West.
As Nevada's only public medical school, UNR Med carries an explicit public-health mandate: addressing care disparities across one of the nation's most underserved rural landscapes. Federal research investment reinforces that mission directly, expanding student research pipelines, enabling interdisciplinary collaboration, and driving clinical innovation tied to real-world community health challenges.
The institution characterized this recognition as both a milestone and a forward-looking benchmark, signaling an intent to continue climbing national research rankings in the years ahead.
More broadly, the University of Nevada, Reno has been consolidating its status as a top public research institution. The University has retained its Carnegie “R1: Very High Research Activity” designation through 2025, reflecting record levels of external grants and doctoral production across disciplines. In national rankings, UNR is listed among the country’s best public universities, placing in the top 200 National Universities and around the top 100 public institutions in the 2026 U.S. News & World Report tables. On campus, President Brian Sandoval has highlighted all‑time highs in Honors College enrollment, growth in faculty elected as American Association for the Advancement of Science fellows, and a series of new strategic plans and impact initiatives in science, liberal arts and other colleges — signs that the institution’s research, teaching and community‑engagement profile is rising in tandem with UNR Med’s advances.
📎 Read full article on K-EnterTech Hub →
About K-EnterTech Forum · K-엔터테크포럼
K-EnterTech Forum (K-ETF, K-엔터테크포럼)은 엔터테인먼트 테크놀로지, K-콘텐츠, 한류, 미디어 정책 분야의 전문 인사이트를 제공하는 국내 대표 플랫폼입니다. K-팝·K-드라마·K-푸드·K-컬처와 AI·스트리밍·크리에이터 이코노미·방송 기술의 공진화(Co-Evolution) 전략을 연구하고, 국내외 포럼·행사를 통해 정책 및 산업 협력 의제를 이끌고 있습니다.
K-EnterTech Forum is Korea's leading platform for insights on entertainment technology, K-Content, Hallyu, and media policy — bridging Korean cultural industries with global technology trends.
고삼석 상임의장 · Chairman Samseog Ko
고삼석(Ko Samseog)은 K-EnterTech Forum 상임의장입니다. 동국대학교 첨단융합대학 석좌교수이자 국가인공지능전략위원회 분과위원으로, 30년 이상의 방송통신 정책 및 산업 경험을 바탕으로 K-콘텐츠와 글로벌 엔터테인먼트 기술의 융합을 선도하고 있습니다. 前 방송통신위원회 상임위원을 역임했으며, ZDNet Korea에 정기 칼럼을 연재 중입니다.
Samseog Ko is the founding Chairman (상임의장) of K-EnterTech Forum. He is a Distinguished Professor at Dongguk University and a member of Korea's National AI Strategy Committee. Former Commissioner of the Korea Communications Commission (KCC).
📩 familygang@naver.com | 🌐 entertechfrum.com | 고삼석 상임의장 소개 →
